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Available online 4 May 2011Through the last two decades, there has been a significant
progress on the understanding of the nature of various
congenital vascular malformations (CVMs), and the confu-
sion based on old name-based eponyms and classification is
now sufficiently cleared. Further, contemporary concept on
the CVMs and its management by a multidisciplinary
approach are now fully established.
However, current knowledge is not sufficient enough to
correct many unfair prejudices with a proper answer, and
questions such as the aneurysm of congenital origin as the
result of a birth defect remain to be answered.
Among the arteriovenous malformations (AVMs),
aneurysm formation along the feeding artery and/or
draining veins is not rare at all; it is a ‘well anticipated’
haemodynamic reaction/consequence to such ‘high flow’
lesions.
Together with a tortuosity, saccular or fusiform dilata-
tion of the vessels is a common complication along the
natural course of the progress of such lesion, when left
alone.
Therefore, all the extratruncular AVM lesions should be
considered as candidates for aggressive control ‘before’
they progress to cause such potentially limb-threatening
condition (e.g., aneurysmal rupture).DOI of original article: 10.1016/j.ejvs.2011.04.016.
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doi:10.1016/j.ejvs.2011.04.017However, such extratruncular lesions are the embryonic
tissue remnant following the developmental defect along
the “earlier” stage of embryogenesis, so that all of them
possess mesenchymal cell characteristics of an evolutionary
power to grow when stimulated (e.g., female hormone,
menarche, pregnancy, trauma, surgery and so on).1,2
Therefore, complete destruction of the ‘nidus’ of the
lesion is warranted for effective control of the lesion, and
the once popular approach with ligation of the feeding
artery due to misunderstanding is now condemned, as it
only provokes the lesion to enhance neo-vascular recruit-
ment to make the condition worse.
As the authors correctly pointed out, without proper
control of the AVM lesion itself as the primary cause of the
aneurysm, recurrentaswell asdenovoaneurysmdevelopment
is an unavoidable consequence. Further, a life-/limb-saving
surgical ligation of the ruptured aneurysm alone would rather
causemore stimulation and should be followed by appropriate
management of the AVM (e.g., ethanol sclerotherapy).
Contrary tothis ‘secondary(?)’aneurysmastheconsequence
of the AVM lesions, a ‘primary’ arterial/venous aneurysm is
relatively rare and classified separately to ‘truncular’ arterial
malformation (AM)/truncular venous malformation (VM).
‘Truncular’ malformation is an outcome of birth defect
along the “later” stage of embryogenesis so that it no longer
possessesmesenchymal cell characteristics as extratruncular
lesions. Instead, various conditions involving the vessel wall,
such as a dilatation, occlusion/stenosis and defective vessel
structures (e.g., web and membrane), would cause onlyd by Elsevier Ltd. All rights reserved.
524 B.B. Leehaemodynamic impacts depending upon their severity,
extent and location (e.g., absence of femoral artery).
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